Skip to content
Discover J&J
Medicines & therapies
Medical devices & technology
Discover J&J
Medicines & therapies
Medical devices & technology
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Policy Briefs
Perspectives
& insights
About us
Menu
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Policy Briefs
Perspectives
& insights
About us
Show Search
Search Query
Submit Search
Clear
Dictate search request
Search Results
No Results
Recently Viewed
Listening...
Sorry, I don't understand. Please try again
Home
/
Content library
Content library
Explore all content
Search Query
Submit Search
Clear
Dictate search request
Listening...
Sorry, I don't understand. Please try again
33 Results
33 Results
Open
Filters
Sort By
Newest
Newest
Oldest
Relevance
Perspectives & insights
Why “one-size-fits-all” economics doesn’t work in U.S. healthcare
April 16, 2025
Read more
Research: Value
A review of heterogeneity in comparative economic analysis
With specific considerations for the decentralized U.S. setting and patient-centered care
March 8, 2025
Read more
Perspectives & insights
Every second counts: The impact of FDA’s Accelerated Approval Program
March 5, 2025
Read more
Transparency
The 340B Program
January 30, 2025
Read more
Access
Economic evidence on cost sharing and alternative insurance designs
Addressing moral and behavioral hazards in high-income healthcare systems: a systematic review
November 14, 2024
Read more
Research: Innovation
Public sector replacement of privately funded pharmaceutical R&D
Cost and efficiency considerations
October 3, 2024
Read more
Transparency
2023 Johnson & Johnson Innovative Medicine U.S. pricing transparency report
Creating the next era of healthcare advancements for patients
September 1, 2024
Read more
Transparency
$42.8 billion: breaking it down
2023 Rebates, discounts and fees
September 1, 2024
Read more
Transparency
2023 rebates, discounts and fees
September 1, 2024
Read more
Research: Innovation
Comprehensive measurement of biopharmaceutical R&D investment
August 6, 2024
Read more
Previous
2 of 4
Next
